Historia, funkcje i struktura głównego układu zgodności tkankowej

• Autorzy: Urtnowski P. , Oprzadek J. , Pawlik A. , Brzozowska A. , Sender G.

Warianty tytułu

EN

Major histocompatibility complex (MHC) history, structure and function

• Języki publikacji: PL

Abstrakty

EN

Contemporary research about the histocompatibility of humans and animals is derived from the experimental medical studies on tumors and blood group serology in mice. Major histocompatibility complex (MHC) was discovered and described in the mid-1930s, while the elements determining the acceptance or rejection of tumor tissue have been studied in mice. Since the discovery of the first antigen in the human histocompatibility complex (HLA-A2), there has been a rapid development of research regarding the diversity of MHC molecules, as well as their encoding genes in human, mouse and livestock. Currently, three subgroups of MHC molecules have been identified, differing in terms of both structure and function. Over the last three decades, a number of analytical methods aimed at the accurate characterization of human and livestock MHC gene polymorphism have been used. The first techniques made it possible to define the differences in protein products. The turn of the 1980s and the 1990s has witnessed studies in which molecular biology techniques were used for the identification of alleles and genotypes of MHC in humans and animals. Genes of this complex can be used as genetic markers for susceptibility or resistance to various diseases. Due to the very broad possibilities for the use of the relationship between MHC and the susceptibility (resistance) of animals to diseases, comprehensive studies of this issue have been conducted on farm animals.

Słowa kluczowe

PL

glowny uklad zgodnosci tkankowej; struktura; funkcje; geny MHC; bialka MHC

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2013
• Tom: 69
• Numer: 10
• Opis fizyczny: s.592-596,tab.,bibliogr.

Twórcy

autor

Urtnowski P.

• Instytut Genetyki i Hodowli Zwierząt, Polska Akademia Nauk, ul. Postępu 36A, Jastrzębiec 05-552 Magdalenka

autor

Oprzadek J.

• Instytut Genetyki i Hodowli Zwierząt, Polska Akademia Nauk, ul. Postępu 36A, Jastrzębiec 05-552 Magdalenka

autor

Pawlik A.

• Instytut Genetyki i Hodowli Zwierząt, Polska Akademia Nauk, ul. Postępu 36A, Jastrzębiec 05-552 Magdalenka

autor

Brzozowska A.

• Instytut Genetyki i Hodowli Zwierząt, Polska Akademia Nauk, ul. Postępu 36A, Jastrzębiec 05-552 Magdalenka

autor

Sender G.

• Instytut Genetyki i Hodowli Zwierząt, Polska Akademia Nauk, ul. Postępu 36A, Jastrzębiec 05-552 Magdalenka

Bibliografia

• 1. Aguado B., Bahram S., Beck S., Campbell R. D., Forbes S. A., Geraghty D., Guillaudeux T., Hood L., Horton R., Inoko H., Janer M., Jasoni C., Madan A., Milne S., Neville M., Oka A., Qin S., Ribas-Despuing G., Rogers J., Rowen L., Shiina T., Spies T., Tamiya G., Tashiro H., Trowsdale J., Vu Q., Williams L., Yamazaki M.: The MHC sequencing consortium. Complete sequence and gene map of human major histocompatibility complex. Nature 1999, 401, 921-923.
• 2. Amorena B., Stone W.: Serologically defined (SD) locus in cattle. Science 1978, 201, 159-160.
• 3. Andersson L., Lundén A., Sigurdardottir S., Davies C., Rask L.: Linkage relationships in the bovine MHC region. High recombination frequency between class II subregions. Immunogenetics 1988, 27, 273-280.
• 4. Ansari H. A., Hediger R., Fries R., Stranzinger G.: Chromosomal localization of the major histocompatibility complex of the horse (ELA) by in situ hybridization. Immunogenetics 1988, 28, 362-364.
• 5. Bjorkman P. J., Saper M. A., Samraoui B., Bennett W. S., Strominger J. L., Wiley D. C.: Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987a, 329, 506-512.
• 6. Bloom S., Bacon L.: Linkage of the major histocompatibility (B) complex and the nucleolar organizer region in the chicken. Heredity 1985, 76, 146-154.
• 7. Briles W. E., Stone H. A., Cole R. K.: Marek's disease: effects of B histocompatiblity alloalleles in resistant and susceptible chicken lines. Science 1977, 195, 193-195.
• 8. Brown J. H., Jardetzky T. S., Gorga J. C., Stern L. J., Urban R. G., Srtominger J. L., Wiley D. C.: Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993, 364, 33-39.
• 9. Chicz R. M., Urban R. B., Gorga J. C., Vignali D. A., Lane W. S., Strominger J. L.: Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 1993, 178, 27-47.
• 10. Dausset J.: 1958 - Iso-leuco-antibodies. Acta Haematologia 1975, 20, 156-166.
• 11. Davies C. J., Antczak D. F.: Mixed Lymphocyte culture studies reveal complexity in the bovine MHC not detected by class I serology. Anim. Genetics 1991a, 22, 31-44.
• 12. Davies C. J., Joosten I., Bernoco D., Arriens M. A., Bester J., Ceriotti G., Ellis S., Hensen E. J., Hines H. C., Horin P., Kristensen B., Lewin H. A., Meggiolaro D., Morgan A. L. G., Morita M., Nolsson Ph. R., Oliver R. A., Orlova A., Østergarrd H., Park C. A., Schubert H. J., Simon M., Spooner R. L., Stewart J. A.: Polymorphism of bovine MHC class I genes. Joint report of the fifth international bovine lymphocyte antigen (BoLA) workshop. Int. J. Immunogenetics 1994, 21, 239-258.
• 13. Garcia K. C., Degano M., Stanfield R. L., Brunmark A., Jackson M. R., Peterson P. A., Teyton L., Wilson I. A.: An alphabeta T cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex. Science 1996, 274, 209-219.
• 14. Gołąb J., Jakóbisiak M., Lasek W., Stokłosa T.: Immunologia. Wydawnictwo Naukowe PWN, Warszawa 2008.
• 15. Gorer P. A.: The antigenic basis of tumour transplantation. J. Pathol. Bacteriol. 1938, 47, 231-252.
• 16. Gruen J. R., Weissman S. M.: Evolving views of the major histocompatibility complex. Blood 1997, 90, 4252-4265.
• 17. Hedrick P. W., Kim T. J.: Genetics of complex polymorphism: parasites and maintenance of MHC variation. In Evolutionary Genetics: from molecules to morphology, edited by R. Singh and C. Krimbas. Harvard University Press, Cambridge 2000, 204-234.
• 18. Hill A. V., Allsopp C. E., Kwiatkowski D., Anstey N. M., Twumasi P., Rowe P. A., Bennett S., Brewster D., Mcmichael A. J., Greenwood B. M.: Common west African HLA antigens are associated with protection from severe malaria. Nature 1991, 352, 595-600.
• 19. Horton R., Wilming L., Rand V., Lovering R. C., Bruford E. A., Khodiyar V. K., Lush M. J., Povey S., Talbot C. C. Jr., Wright M. W., Trowsdale J., Ziegler A., Beck S.: Gene map of the extended human MHC. Nat. Rev. Genet. 2004, 12, 889-899.
• 20. Joosten I. Sanders M. F., van der Poel A., Williams J. L., Hepkema B. G., Hensen E. J.: Biochemically defined polymorphism of bovine MHC class II antigens. Immunogenetics. 1989, 29, 213-216.
• 21. Klein J.: Biology of the Mouse Histocompatibility-2 Complex. Principles of Immunogenetics Applied to a Single System. 1975, Pp. 620.
• 22. Kulski J. K., Shiina T., Anzai T., Kohara S., Inoko H.: Comparative genomic analysis of the MHC: the evolution of class I duplication blocks, diversity and complexity from shark do man. Immunological Review. 2002, 190, 95-122.
• 23. Lechler R.: The roles of class I and class II molecules of the major histocompatibility complex in T cell immunity, [w:] R. Lechler (ed.): HLA and disease. Academic Press 1994, 49-102.
• 24. Paterson S., Wilson K., Pemberton J. M.: Major histocompatibility complex variation associated with juvenile survival and parasite resistance in a large unmanaged ungulate population (Ovis aries L.). Evol. 1998, 95, 3714-3719.
• 25. Penn D. J.: Major Histocompatibility Complex (MHC). Encyclopedia of Life Sciences. Macmilan Publishers 2002, 1-7.
• 26. Scotto G., Fazio V., D’Alessandro G., Monno L., Saracino A., Palumbo E., Angaeano G.: Association between HLA class II antigens and Hepatitis C virus infection. J. Biol. Regul. Homeost. Agents 2003, 17, 316-321.
• 27. Sinigaglia F., Hammer J.: Defining rules for the peptide-MHC class II interaction. Current Opinion in Immunology 1994, 6, 52-56.
• 28. Smith D. A., Germolec D. R.: Introduction to Immunology and Autoimmunity. Environmental Health Prospectives 1999, 107, 661-665.
• 29. Snell G. D.: The genetics of transplantation. Journal of National Cancer Institute 1953, 14, 691.
• 30. Teale A. J., Morrison W. I., Goddeeris B. M., Groocock C. M., Stagg D. A., Spooner R. L.: Bovine alloreactive cytotoxic cells generated in vitro: target specificity in relation to BoLA phenotype. Immunology 1985, 55, 355-362.
• 31. Thursz M., Kwiatkowski D., Allsop K.: Association between an MHC class II allele and clearance of Hepatitis B virus in the Gambia. New Engl. J. Med. 1995, 332, 1065-1069.
• 32. Tilamamm H. L., Chen D.-F., Trautwein C., Kliem V., Grundey A., Berning-Haag A., Boker K., Kubicka S., Pastucha L., Stangel W., Manns M. P.: Low frequency of HLA-DBR1*11 in hepatitis C virus induced end stage liver disease. Gut 2001, 48, 714-718.
• 33. Toh H., Savoie Ch. J., Kamikawaji N., Muta Sh., Sasazuki T., Kuhara S.: Changes at the floor of the Peptide-Binding Groove induce a strong preference for proline at position 3 of the bound peptide: molecular dynamics simulations of HLA-A*0217. Biopolymers 2000, 54, 318-327.
• 34. Vaiman M., Renard C., Lafage P., Amateau J., Nizza P.: Evidence of a histocompatibility system in swine (S-LA). Transplantation 1970, 10, 155.
• 35. Viuff B., Østergard H., Aasted B., Kristensen B.: One-dimensional isoelecric focusing and immunoblotting of bovine major histocompatibility complex (BoLA) class I molecules and correlation with class I serology. Anim. Genetics 1991, 22, 147-154.
• 36. Zinkernagel R. M., Doherty P. C.: Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semianogeneic system. Nature 1974, 248, 701-702.